Congenica secures new two-year contract with Hong Kong Genome Project
Congenica announces a two-year extension to their contract with the Hong Kong Genome Project (HKGP).
Congenica and myTomorrows announce partnership to advance Precision Oncology by facilitating rapid access to clinical trials
Congenica and myTomorrows have partnered to expedite access to precision oncology for cancer patients worldwide.
Congenica co-founder Professor Richard Durbin awarded the 39th International Prize for Biology
Congenica Informatics Director Richard Durbin has been awarded the International Prize for Biology by the Japan Society of the Promotion of Science.
Congenica and NoorDx deliver sample-to-report services across the Middle East
Congenica announces a strategic partnership with NoorDx, an innovative clinical genomics and research services company in Saudi Arabia.
The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology
Philip Beer presented a webinar exploring one of the key challenges that we are currently facing when applying genomic testing in cancer.
The time has come to change the way we treat cancer
Professor Andrew Biankin shares his experiences in transforming cancer care with genomic testing.
The Road to Diagnosis: How Genetics Transforms the Lives of Rare Disease Patients
In recognition of Rare Disease Day, Congenica looks at the importance of a genetic diagnosis for patients and asks, what's next for rare disease?
Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute
Co-founder and Scientific Director at Congenica, Professor Matt Hurles, has today been appointed as Director of The Wellcome Trust Sanger Institute.
What’s it like to be a woman working in science?
For International Day of Women and Girls in Science, we talk to three women at Congenica about their experiences of working in STEM.
Professor Matthew Hurles discusses the Deciphering Developmental Disorders study
Professor Matthew Hurles, project lead for DDD study and Congenica founder, discsuses his projects, advancements in data analysis and interpretation
Congenica announces Early Access Program for its novel Precision Oncology Solution
Congenica launches early access program for its new CE-IVD Precision Oncology Solution
Congenica approved as supplier on Government G-Cloud 13 framework
Congenica is an approved supplier on UK Government G-Cloud 13 framework